Non-Ionizing Breast Imaging Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook

Global Non-Ionizing Breast Imaging Market - Size, Share, Demand, Industry Trends and Opportunities

Global Non-Ionizing Breast Imaging Market, By Type (Breast Ultrasound, Breast MRI, Automated Whole-breast Ultrasound (AWBU), Breast thermography, Electric Impedance Tomography, Optical Imaging), End User (Hospital, Diagnostic Imaging Centre, Others) – Industry Trends.

The non-ionizing breast imaging market was valued at USD 4.02 billion in 2021 and is expected to reach USD 7.77 billion by 2029, registering a CAGR of 8.60% in 2022-2029. The "breast ultrasound" accounts for the largest type segment in the non-ionizing breast imaging market within the forecasted period owing to the lower risk of exposure to radiation and the various benefits such as the ability to detect lesions and the ability to differentiate between a cyst and a solid mass and the detection of blood flow through vessels. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Access Full 350 Pages PDF Report @

https://www.databridgemarketresearch.com/reports/global-non-ionizing-breast-imaging-market

**Segments**

- Type: The non-ionizing breast imaging market can be segmented based on type into electrical impedance imaging, optical imaging, and microwave imaging. Electrical impedance imaging involves measuring the electrical properties of breast tissues to detect abnormalities. Optical imaging uses light-based techniques like diffuse optical spectroscopy and optical coherence tomography. Microwave imaging utilizes microwave signals to generate images of breast tissues.

- Modality: Segmentation based on modality includes handheld devices, benchtop devices, and wearable devices. Handheld devices are portable and easy to use, suitable for point-of-care diagnostics. Benchtop devices are larger and provide higher imaging quality but are less portable. Wearable devices offer continuous monitoring and are convenient for long-term use.

- End User: The market can also be segmented by end user, including hospitals, diagnostic imaging centers, and research institutes. Hospitals require advanced imaging technologies for accurate diagnosis and treatment planning. Diagnostic imaging centers specialize in imaging services and cater to patients referred by healthcare providers. Research institutes focus on developing and testing new imaging technologies for breast cancer detection.

**Market Players**

- GE Healthcare: A leading player in the non-ionizing breast imaging market, GE Healthcare offers a range of imaging solutions, including ultrasound and optical imaging systems for breast cancer detection.

- Koninklijke Philips N.V.: Philips provides innovative non-ionizing breast imaging technologies such as electrical impedance imaging systems for early breast cancer detection and monitoring.

- Siemens Healthineers: Siemens offers advanced non-ionizing breast imaging modalities like microwave imaging systems for improved cancer detection and patient outcomes.

- Hologic, Inc.: Hologic is a key player in the non-ionizing breast imaging market, known for its expertise in developing cutting-edge imaging devices for breast cancer screening and diagnosis.

- Toshiba Medical Systems Corporation: Toshiba Medical Systems delivers high-quality non-ionizing breast imaging solutions, including optical imaging systems, to support early detection and treatment of breast cancer.

The global non-ionizing breast imaging market is witnessing significant growth due to increasing awareness about breastThe global non-ionizing breast imaging market is experiencing robust growth driven by several key factors. Increasing awareness about breast cancer screening and the importance of early detection among women worldwide is a primary driver of market expansion. Advances in non-ionizing imaging technologies have led to improved accuracy, sensitivity, and specificity in detecting breast abnormalities, contributing to the market's growth trajectory. Moreover, the rising prevalence of breast cancer cases globally, coupled with the growing need for non-invasive imaging modalities with reduced risk, has further fueled the demand for non-ionizing breast imaging solutions.

The segmentation of the non-ionizing breast imaging market based on type plays a crucial role in addressing specific clinical needs and preferences. Electrical impedance imaging, optical imaging, and microwave imaging each offer unique advantages and applications in breast cancer detection. Electrical impedance imaging provides insights into tissue composition and electrical properties, offering a non-invasive approach to identifying abnormalities. Optical imaging techniques leverage light-based technologies to visualize tissue structures and cellular changes in the breast. Microwave imaging, on the other hand, utilizes microwave signals to generate detailed images of breast tissues, enabling enhanced characterization of lesions.

The modality segmentation of the market into handheld devices, benchtop devices, and wearable devices caters to diverse end-user requirements and preferences. Handheld devices offer portability and ease of use, making them suitable for point-of-care applications and decentralized settings. Benchtop devices, although less portable, provide higher imaging quality and performance, making them ideal for clinical settings requiring advanced imaging capabilities. Wearable devices represent a growing trend in non-ionizing breast imaging, offering continuous monitoring and convenience for long-term usage, especially in research and monitoring applications.

End-user segmentation of the market into hospitals, diagnostic imaging centers, and research institutes reflects the diverse settings where non-ionizing breast imaging technologies are utilized. Hospitals require advanced imaging systems to support accurate diagnosis and treatment planning for breast cancer patients. Diagnostic imaging centers specialize in providing imaging services, catering to a wide range of patients referred for breast cancer screening and diagnosis**Segments:**

- Type: The segmentation of the non-ionizing breast imaging market based on type into electrical impedance imaging, optical imaging, and microwave imaging allows for tailored approaches to breast cancer detection. Each type offers unique benefits in terms of detecting abnormalities and providing detailed imaging of breast tissues.

- Modality: Segmentation by modality into handheld devices, benchtop devices, and wearable devices addresses the varying needs of end users. Handheld devices offer portability and ease of use, while benchtop devices provide higher imaging quality. Wearable devices allow for continuous monitoring, catering to long-term usage preferences.

- End User: Segmenting the market by end user into hospitals, diagnostic imaging centers, and research institutes reflects the diverse settings where non-ionizing breast imaging technologies are utilized. Hospitals require advanced imaging solutions for accurate diagnosis and treatment planning, while diagnostic imaging centers focus on imaging services for referred patients. Research institutes play a vital role in developing and innovating new imaging technologies for breast cancer detection.

**Market Players:**

- GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Hologic, Inc., and Toshiba Medical Systems Corporation are key players driving innovation and growth in the non-ionizing breast imaging market. These companies offer advanced imaging solutions to meet the evolving needs of healthcare providers and patients.

Highlights of TOC:

Chapter 1: Market overview

Chapter 2: Global Non-Ionizing Breast Imaging Market

Chapter 3: Regional analysis of the Global Non-Ionizing Breast Imaging Market industry

Chapter 4: Non-Ionizing Breast Imaging Market segmentation based on types and applications

Chapter 5: Revenue analysis based on types and applications

Chapter 6: Market share

Chapter 7: Competitive Landscape

Chapter 8: Drivers, Restraints, Challenges, and Opportunities

Chapter 9: Gross Margin and Price Analysis

Countries Studied:

1. North America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
2. Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
3. Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
4. Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Browse Trending Reports:

Acoustic Neuroma Market
Anti Rosacea Agents Market
Biliary Atresia Treatment Market
Water Soluble Packaging Market
Display Quantum Dots Market
Arnold-Chiari Treatment Market
Allergic Conjunctivitis Drugs Market
Defense Cyber Warfare Market
Breweries Market
Electrophysiology Ablation Catheters Market
Automotive Charge Air Cooler Market
Alcoholic Psychosis Treatment Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"